Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05536401 · ClinicalTrials.gov registry record · NA
P200TE Agreement and Precision Study
A NA study, sponsored by Optos.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05536401: Clinical Trial NA study, sponsored by Optos.
NCT05536401 is a NA study that was terminated before completion, run by Optos. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05536401, a NA study, was terminated before completion, sponsored by Optos.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is a prospective comparative, randomized, single center study to assess agreement and precision of the P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
Interventions
- DEVICE P200TE
- DEVICE Predicate Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-09-02 |
| Est. Completion | 2022-09-20 |
| Phase | NA |
Why NCT05536401 stopped before completion
NCT05536401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which P200TE is the first listed.
NCT05536401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05536401 about?
NCT05536401 is a clinical study titled "P200TE Agreement and Precision Study". This study is a prospective comparative, randomized, single center study to assess agreement and precision of the P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
What is the current status of trial NCT05536401?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2022-09-02. Estimated completion is 2022-09-20.
What interventions are being tested in trial NCT05536401?
The interventions under investigation include: P200TE (DEVICE), Predicate Device (DEVICE).
Who is sponsoring clinical trial NCT05536401?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05536401's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI